The role of COX-2 in rectal cancer treated with preoperative radiotherapy

[1]  Bernard Leduc,et al.  Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  P. Coucke,et al.  Preoperative hyper-fractionated accelerated radiotherapy (HART) in locally advanced rectal cancer (LARC) immediately followed by surgery. A prospective phase II trial. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[3]  J. Geradts,et al.  Cyclooxygenase-2 (COX-2) Levels Before and After Chemotherapy: A Study in Rectal Cancer , 2005, American journal of clinical oncology.

[4]  Laurence Collette,et al.  Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results--EORTC 22921. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  M. Schwab,et al.  Cyclooxygenase-2 Expression in Human Colorectal Cancer Is Unrelated to Overall Patient Survival , 2005, Clinical Cancer Research.

[6]  K. Sugihara,et al.  Cyclooxygenase-2 Expression , 2004, Clinical Cancer Research.

[7]  B. Yalcin,et al.  Expression of Cox-2 protein in radioresistant laryngeal cancer. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

[8]  W. Hohenberger,et al.  Preoperative versus postoperative chemoradiotherapy for rectal cancer. , 2004, The New England journal of medicine.

[9]  K. Nakashiro,et al.  Overexpression of cyclooxygenase-2 is associated with radioresistance in oral squamous cell carcinoma. , 2004, Oral oncology.

[10]  K. Ang,et al.  Potentiation of tumor response to radiation or chemoradiation by selective cyclooxygenase-2 enzyme inhibitors. , 2004, International journal of radiation oncology, biology, physics.

[11]  L. Milas.  Cyclooxygenase-2 (COX-2) Enzyme Inhibitors and Radiotherapy: Preclinical Basis , 2003, American journal of clinical oncology.

[12]  B. Glimelius.  Role of Adjuvant Chemoradiotherapy for Abdominal Malignancies , 2003, Digestive Surgery.

[13]  Z. Liao,et al.  Improvement of radiotherapy or chemoradiotherapy by targeting COX-2 enzyme. , 2003, Oncology.

[14]  H. Putter,et al.  Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in The Netherlands , 2002, The British journal of surgery.

[15]  G. Noël,et al.  Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer , 2002 .

[16]  C. Suh,et al.  Overexpression of cyclooxygenase‐2 is associated with a poor prognosis in patients with squamous cell carcinoma of the uterine cervix treated with radiation and concurrent chemotherapy , 2002, Cancer.

[17]  M. Kasuga,et al.  Effect of Helicobacter pylori‐Induced Cyclooxygenase‐2 on Gastric Epithelial Cell Kinetics: Implication for Gastric Carcinogenesis , 2002, Helicobacter.

[18]  Hong Zhang,et al.  Overexpression of cyclooxygenase-2 correlates with advanced stages of colorectal cancer , 2002, American Journal of Gastroenterology.

[19]  G. Haroske,et al.  COX-2 expression in rectal carcinoma: immunohistochemical pattern and clinical outcome. , 2002, Anticancer research.

[20]  P. Coucke,et al.  Importance of tumor regression assessment in predicting the outcome in patients with locally advanced rectal carcinoma who are treated with preoperative radiotherapy , 2002, Cancer.

[21]  Rieken,et al.  [Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer]. , 2001, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

[22]  H. Choy,et al.  A selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[23]  J. Holden,et al.  Elevated cyclooxygenase-2 expression correlates with diminished survival in carcinoma of the cervix treated with radiotherapy. , 2001, International journal of radiation oncology, biology, physics.

[24]  S. Neuhausen,et al.  Breast cancer after mantle irradiation for Hodgkin's disease: correlation of clinical, pathologic, and molecular features including loss of heterozygosity at BRCA1 and BRCA2. , 2001, International journal of radiation oncology, biology, physics.

[25]  P. Hermanek.  Role of the surgeon as a variable in the treatment of rectal cancer. , 2000, Seminars in surgical oncology.

[26]  M. Tachibana,et al.  Cyclooxygenase-2 expression correlates with tumor neovascularization and prognosis in human colorectal carcinoma patients. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[27]  I. Gibbs,et al.  Radiation induces upregulation of cyclooxygenase-2 (COX-2) protein in PC-3 cells. , 2000, International journal of radiation oncology, biology, physics.

[28]  T. Tsuruo,et al.  Cyclooxygenase-2 overexpression correlates with tumour recurrence, especially haematogenous metastasis, of colorectal cancer , 2000, British Journal of Cancer.

[29]  K. Seibert,et al.  Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors. , 2000, Cancer research.

[30]  P. Tofilon,et al.  Preferential enhancement of tumor radioresponse by a cyclooxygenase-2 inhibitor. , 2000, Cancer research.

[31]  R. DuBois,et al.  The role of cyclooxygenases in inflammation, cancer, and development , 1999, Oncogene.

[32]  K. Sheahan,et al.  The relationship between cyclooxygenase-2 expression and colorectal cancer. , 1999, JAMA.

[33]  P. Tofilon,et al.  Enhancement of Tumor Response to γ-Radiation by an Inhibitor of Cyclooxygenase-2 Enzyme , 1999 .

[34]  T. Fahey,et al.  Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer. , 1999, Cancer research.

[35]  J. Shah,et al.  Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck. , 1999, Cancer research.

[36]  P. Lipsky,et al.  Cyclooxygenase in biology and disease , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[37]  L Påhlman,et al.  Improved survival with preoperative radiotherapy in resectable rectal cancer. , 1997, The New England journal of medicine.

[38]  R. DuBois,et al.  Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[39]  J. Morrow,et al.  Epidermal growth factor receptor activation induces nuclear targeting of cyclooxygenase-2, basolateral release of prostaglandins, and mitogenesis in polarizing colon cancer cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[40]  William L. Smith,et al.  Prostaglandin Endoperoxide H Synthases (Cyclooxygenases)-1 and −2* , 1996, The Journal of Biological Chemistry.

[41]  S. Reddy,et al.  Inflammation, reproduction, cancer and all that…. The regulation and role of the inducible prostaglandin synthase , 1995, BioEssays : news and reviews in molecular, cellular and developmental biology.

[42]  R. DuBois,et al.  Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2 , 1995, Cell.

[43]  M. Kondo,et al.  Expression of cyclooxygenase-1 and -2 in human colorectal cancer. , 1995, Cancer research.

[44]  R. Coffey,et al.  Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. , 1994, Gastroenterology.

[45]  P. Quirke,et al.  LOCAL RECURRENCE OF RECTAL ADENOCARCINOMA DUE TO INADEQUATE SURGICAL RESECTION Histopathological Study of Lateral Tumour Spread and Surgical Excision , 1986, The Lancet.

[46]  R. Heald,et al.  RECURRENCE AND SURVIVAL AFTER TOTAL MESORECTAL EXCISION FOR RECTAL CANCER , 1986, The Lancet.

[47]  R. Weller,et al.  International Histological Classification of Tumours , 1981 .

[48]  Leslie H. Sobin,et al.  TNM Classification of Malignant Tumours, 7th Edition , 2009 .

[49]  Megumi Baba,et al.  Cyclooxygenase-2 expression correlates with uPAR levels and is responsible for poor prognosis of colorectal cancer , 2004, Clinical & Experimental Metastasis.

[50]  Y. Joo,et al.  Expression of cyclooxygenase-2 protein in colorectal carcinomas , 2002, International journal of gastrointestinal cancer.

[51]  P. Tofilon,et al.  Enhancement of tumor response to gamma-radiation by an inhibitor of cyclooxygenase-2 enzyme. , 1999, Journal of the National Cancer Institute.

[52]  J. Shah,et al.  Cyclooxygenase-2 Expression Is Up-Regulated in Squamous Cell Carcinoma of the Head and Neck 1 , 1999 .